STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1437 by analyst upside · 2026-06-27
RDNT
RadNet, Inc.
Healthcare · Market Cap $5B · P/E 0x
ANALYST PRICE TARGET
+47.8%
implied upside to consensus target
Current Price $60.74
Consensus Target $89.75
Bull Target $100.0
Bear Target $65.0
Analysts Covering 8
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
6
Hold
0
Sell
0
52-Week Low $50.76
52-Week High $85.84
YTD Return -14.4%
FUNDAMENTALS
Market Cap $5B
P/E Ratio (TTM) N/A
Forward P/E 64.4x
EPS (TTM) $-0.17
PEG Ratio 0.96
Dividend Yield N/A
Revenue (TTM) $2.1B
Profit Margin -0.7%
52-WEEK RANGE
52-Week Low $50.76
52-Week High $85.84
Current Price $60.74
Bear Target $65.0
Bull Target $100.0
● Now $60.74 ● Target $89.75
TRADING DATA
Avg Volume 841K
YTD Return -14.4%
Analyst Count 8
Consensus Buy
Upside to Target +47.8%
Last Updated 2026-06-27

ANALYST SUMMARY

RadNet, Inc. (RDNT) is currently trading at $60.74 with a Wall Street consensus price target of $89.75, implying potential upside of 47.8% over the next 12 months. 8 analysts currently cover RDNT, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $100.0, while the most cautious has a target of $65.0.

RDNT operates in the Healthcare sector with a market capitalisation of $5B. The stock is down 14.4% year-to-date and is currently trading near the lower end of its 52-week range of $50.76 – $85.84.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for RDNT, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays — Reiterated
Overweight → Overweight 2026-05-20 Building track record
Barclays — Reiterated
Overweight → Overweight 2026-04-21 Building track record
Keybanc ● Initiated
Overweight 2026-01-09 Building track record
B. Riley Securities — Reiterated
Buy → Buy 2025-12-01 17% win rate (6 calls)
Barclays — Reiterated
Overweight → Overweight 2025-11-13 Building track record
Truist Securities — Reiterated
Buy → Buy 2025-11-12 Building track record
Barclays — Reiterated
Overweight → Overweight 2025-09-03 Building track record
Truist Securities — Reiterated
Buy → Buy 2025-09-03 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
62
out of 100
Coverage depth
17/30
Consensus clarity
18/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →